Rwanda

The Rwanda Food and Drugs Authority (Rwanda FDA), established under Law No. 60/2018 governing food and drugs in Rwanda, serves as the primary national regulatory authority responsible for the registration, licensing, and post-market surveillance of health products including pharmaceuticals, medical devices, diagnostics, and digital health solutions. The Rwanda FDA operates under the Ministry of Health and follows a structured dossier-based review process that evaluates safety, quality, and efficacy prior to granting market authorization. Products must be formally registered before they can be legally imported, distributed, or sold in Rwanda, and the authority maintains a national register of approved health products.

Applicants are required to submit technical dossiers aligned with the Common Technical Document (CTD) format, and the Rwanda FDA also recognizes dossiers prepared in accordance with the African Common Technical Document (ACTD) framework supported by the African Medicines Agency (AMA). A local authorized representative or registered agent is mandatory for foreign manufacturers seeking product registration. Rwanda FDA has progressively embraced regulatory reliance pathways, recognizing approvals from stringent regulatory authorities (SRAs) such as the European Medicines Agency (EMA), the United States Food and Drug Administration (US FDA), and Health Canada to expedite review timelines. Rwanda is also an active member of the East African Community (EAC) and participates in regional harmonization efforts coordinated through the EAC Medicines Regulatory Harmonization (MRH) program, which aims to streamline approvals across member states.

Public sector procurement of health products in Rwanda is centrally coordinated through the Rwanda Medical Supply (RMS), a government-owned entity operating under the Ministry of Health that manages forecasting, procurement, warehousing, and distribution of medicines, medical devices, diagnostics, and other health commodities to public health facilities nationwide. The Rwanda Public Procurement Authority (RPPA) establishes the overarching legal and procedural framework governing all public tenders, and major procurements are subject to competitive bidding processes in accordance with national procurement law. The Ministry of Health, in coordination with the Ministry of Finance and Economic Planning, sets strategic priorities and budget allocations for health commodity procurement, ensuring alignment with the national health sector strategic plan.

Rwanda benefits substantially from donor-funded procurement channels, with significant volumes of health products supplied through international agencies and global health financing mechanisms including the Global Fund to Fight AIDS, Tuberculosis and Malaria, USAID and its implementing partners such as PEPFAR, Gavi the Vaccine Alliance, UNICEF Supply Division, and the United Nations Population Fund (UNFPA). Products procured through these channels are often sourced via pre-qualified suppliers and may bypass standard national registration requirements under specific humanitarian or program exemption provisions, though Rwanda FDA oversight is increasingly being integrated even into donor-funded supply chains. Rwanda has articulated ambitions to promote local and regional manufacturing capacity, partly through the Africa CDC and African Union agenda, and preference policies favoring locally or regionally manufactured products are under active development, consistent with the broader Made in Africa strategy and Rwanda's positioning as a regional health hub.